A
Alice J. Stark
Researcher at Medtronic plc
Publications - 6
Citations - 1404
Alice J. Stark is an academic researcher from Medtronic plc. The author has contributed to research in topics: Ventricular tachycardia & Tachycardia. The author has an hindex of 4, co-authored 6 publications receiving 1347 citations.
Papers
More filters
Journal ArticleDOI
Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results
Mark S. Wathen,Paul J. Degroot,Michael O. Sweeney,Alice J. Stark,Mary F. Otterness,Wayne O. Adkisson,Robert C. Canby,Koroush Khalighi,Christian Machado,Donald S. Rubenstein,Kent J. Volosin +10 more
TL;DR: Compared with shocks, empirical ATP for FVT is highly effective, is equally safe, and improves quality of life, measured with the SF-36.
Journal ArticleDOI
Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease
Mark S. Wathen,Michael O. Sweeney,Paul J. Degroot,Alice J. Stark,Jodi Koehler,Michael B. Chisner,Christian Machado,Wayne O. Adkisson +7 more
TL;DR: ATP for FVT may safely reduce the morbidity of painful shocks and is common in ICD patients, and can terminate 3 of 4 of these episodes with a low incidence of acceleration and syncope.
Journal ArticleDOI
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial
Michael O. Sweeney,Mark S. Wathen,Kent J. Volosin,Ismaile Abdalla,Paul J. Degroot,Mary F. Otterness,Alice J. Stark +6 more
TL;DR: Primary prevention patients are slightly less likely to have appropriate therapies than secondary prevention patients, but episode density is similar among patients with appropriate therapies.
Journal ArticleDOI
QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
Alfred E. Buxton,Michael O. Sweeney,Mark S. Wathen,Mark E. Josephson,Mary F. Otterness,Elaine Hogan-Miller,Alice J. Stark,Paul J. Degroot,PainFREE Rx Ii Investigators +8 more
TL;DR: The utility of QRSd to predict VT/VF events in patients with CAD requires further prospective evaluation and the Q RSd and ECG conduction abnormalities are not useful to predict ICD benefit in patients having the characteristics of the authors' study population.